This insight brief explains how the U.S. Drug Supply Chain Security Act (DSCSA) is reshaping pharmaceutical supply chain operations as full interoperability requirements take effect. It outlines key challenges, including serialized data exchange, exception handling, verification workflows, and partner readiness. The brief highlights the importance of end-to-end visibility, standardized data governance, and scalable technology platforms to ensure compliance without disrupting operations. IQVIA emphasizes proactive readiness assessments, cross-ecosystem collaboration, and continuous monitoring to reduce risk, protect patients, and maintain uninterrupted product flow across the U.S. supply chain.

Join for free to read